{"id":49857,"title":"LC-MS\/MS quantitation of insulin, glucagon, somatostatin, and C-peptide ","title_html":"<p>LC-MS\/MS quantitation of insulin, glucagon, somatostatin, and C-peptide <\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":"dx.doi.org\/10.17504\/protocols.io.buw9nxh6","doi_status":2,"uri":"lc-ms-ms-quantitation-of-insulin-glucagon-somatost-buw9nxh6","type_id":4,"template_id":3,"published_on":1620853215,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"buw9nxh6","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1620743676,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"Michael Roper","affiliation":null,"affiliations":[],"username":"m4ule1w1x1x4vle1","note":null,"link":null,"image":{"source":"\/img\/avatars\/014.png","placeholder":"\/img\/avatars\/014.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"},{"id":6,"image":{"source":"\/img\/badges\/accelerator.svg","placeholder":"\/img\/badges\/accelerator.svg"},"name":"Science accelerator"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"has_versions":0,"link":null,"total_collections":0,"number_of_steps":0,"authors":[{"name":"Matthew J. Donohue","affiliation":"Florida State University","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Robert T. Filla","affiliation":"Florida State University","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Daniel J. Steyer","affiliation":"Florida State University","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Wesley J. Eaton","affiliation":"Florida State University","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Michael G. Roper","affiliation":"Florida State University","affiliations":[],"username":null,"note":"","link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/lc-ms-ms-quantitation-of-insulin-glucagon-somatost-buw9nxh6","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":0,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"9302D710B26511EBA103157AB4AEBA44","state_version_id":2318,"steps":[],"document":"<div class = \"text-blocks\"><div class = \"text-block\">This protocol was published as part of: M.J. Donohue, R.T. Filla, D.J. Steyer, W.J. Eaton, M.G. Roper, Rapid liquid chromatography-mass spectrometry quantitation of glucose-regulating hormones from human islets of Langerhans, J. Chrom. A 1637 (2021) 461805<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Chemicals and Reagents<\/span><\/div><div class = \"text-block\"><span>LC grade water (H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O)<\/span><\/div><div class = \"text-block\">LC grade acetonitrile (ACN)<\/div><div class = \"text-block\"><span>Somatostatin-14, ([ring-D<\/span><span style = \"vertical-align:sub;\">5<\/span><span>] Phe<\/span><span style = \"vertical-align:super;\">6<\/span><span>) somatostatin-14 (somatostatin IS) - BaChem<\/span><\/div><div class = \"text-block\"><span>C-peptide trifluoroacetate salt, SILu<\/span><span style = \"vertical-align:super;\">TM<\/span><span>Pep C-peptide (([<\/span><span style = \"vertical-align:super;\">13<\/span><span style = \"vertical-align:super;vertical-align:sub;\">C<\/span><span style = \"vertical-align:sub;\">6<\/span><span>]Leu<\/span><span style = \"vertical-align:super;\">26+30<\/span><span>)-C-peptide) (C-peptide IS) - BaChem and Sigma<\/span><\/div><div class = \"text-block\"><span>Glucagon, ([<\/span><span style = \"vertical-align:super;\">13<\/span><span style = \"vertical-align:super;vertical-align:sub;\">C<\/span><span style = \"vertical-align:sub;\">6<\/span><span>]Leu<\/span><span style = \"vertical-align:super;\">14<\/span><span>)-glucagon (1-29) trifluoroacetate salt (glucagon IS) - Sigma and BaChem<\/span><\/div><div class = \"text-block\"><span>Human insulin, SILu<\/span><span style = \"vertical-align:super;\">TM<\/span><span>Prot insulin, human (([<\/span><span style = \"vertical-align:super;\">15<\/span><span style = \"vertical-align:super;vertical-align:sub;\">N<\/span><span style = \"vertical-align:sub;\">7<\/span><span>] (all amino acids excluding Thr<\/span><span style = \"vertical-align:super;\">30 <\/span><span>in \u03b2 chain)) labeled insulin) (insulin IS) - Sigma<\/span><\/div><div class = \"text-block\">Bovine serum albumin (BSA)<\/div><div class = \"text-block\"><span>Balanced Salt Solution (BSS) was used in certain experiments and was composed of 25 mM tricine, 125 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl<\/span><span style = \"vertical-align:sub;\">2<\/span><span>, and 2.4 mM CaCl<\/span><span style = \"vertical-align:sub;\">2<\/span><span>adjusted to a pH of 7.4 and contained different amounts of glucose as described in the text<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Materials and Instrumentation<\/span><\/div><div class = \"text-block\">Low adsorption autosampler vials<\/div><div class = \"text-block\">Halo Peptide column -  ES-C18, 2.1 X 30 mm, 2.7 \u00b5m, 160 \u00c5<\/div><div class = \"text-block\"><span>Thermo Scientific<\/span><span style = \"vertical-align:super;\">TM<\/span><span>  Vanquish<\/span><span style = \"vertical-align:super;\">TM <\/span><span>Flex UHPLC system with a Split Sampler Module<\/span><span style = \"vertical-align:super;\">TM<\/span><span style = \"vertical-align:super;\"> <\/span><\/div><div class = \"text-block\"><span>Thermo Scientific<\/span><span style = \"vertical-align:super;\">TM<\/span><span> TSQ Quantis<\/span><span style = \"vertical-align:super;\">TM<\/span><span> triple quadrupole mass spectrometer. <\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Preparation and Analysis of Calibration Standards<\/span><\/div><div class = \"text-block\"><span>Solubilize somatostatin, C-peptide, glucagon, insulin, and all IS according to vendor protocols to a concentration of 1 mg mL<\/span><span style = \"vertical-align:super;\">-1<\/span><span> using:<\/span><\/div><div class = \"text-block\"><span>    Somatostatin - H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O <\/span><\/div><div class = \"text-block\"><span>    Somatostatin IS - H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O <\/span><\/div><div class = \"text-block\">    C-peptide - 8.7 M acetic acid <\/div><div class = \"text-block\">    C-peptide IS - 8.7 M acetic acid <\/div><div class = \"text-block\">    Glucagon - 0.05 M acetic acid<\/div><div class = \"text-block\"><span>    Glucagon IS - H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O <\/span><\/div><div class = \"text-block\">    Insulin - 0.01 M HCl <\/div><div class = \"text-block\">    Insulin IS - 0.35 M acetic acid<\/div><div class = \"text-block\">These stock solutions were stored at -20 \u00b0C for long term storage or 4 \u00b0C for short term storage.<\/div><div class = \"text-block\">All water and ACN contain 0.1% formic acid (FA) unless otherwise stated.<\/div><div class = \"text-block\"><span>Hydrolyzed BSA (Hyd-BSA) should be made according to a published protocol.<\/span><span style = \"vertical-align:super;\">1<\/span><\/div><div class = \"text-block\"><span>Final solvent composition of Hyd-BSA is 30:70 ACN:H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O (v:v).<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Calibration curves with BSS<\/span><\/div><div class = \"text-block\">Dilute analyte and IS stock solutions to 2 \u00b5M and 200 nM, respectively (with the exception of insulin IS which was diluted to 50 nM), with Hyd-BSA. <\/div><div class = \"text-block\">Further dilute analyte solutions with BSS containing 1 mM glucose to concentrations of 10, 20, 100, 200, and 400 nM. <\/div><div class = \"text-block\">Dilute 5 \u00b5L of these solutions to 100 \u00b5L via addition of 35 \u00b5L IS and 60 \u00b5L Hyd-BSA.<\/div><div class = \"text-block\">Final concentrations of the analytes are 0.5, 1, 5, 10, and 20 nM and IS concentration is 10 nM.<\/div><div class = \"text-block\"><span style = \"font-weight:bold;font-style:italic;\">Human Islet Experiments - Obtained from ProdoLabs<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Static Incubation of Islets<\/span><\/div><div class = \"text-block\">Wash 250 IEQ with BSS with 1 mM glucose<\/div><div class = \"text-block\">Place islets into a microcentrifuge tube with 50 \u00b5L of BSS with 1 mM glucose<\/div><div class = \"text-block\"><span>Incubate at 37 \u00b0C and 5% CO<\/span><span style = \"vertical-align:sub;\">2<\/span><span> for 2 hrs  <\/span><\/div><div class = \"text-block\">Remove 3 x 5 \u00b5L aliquots from the microcentrifuge tube<\/div><div class = \"text-block\">Add 15 \u00b5L of BSS with 51 mM glucose to the islets to bring the final concentration of glucose to 16 mM and final volume back to 50 \u00b5L.<\/div><div class = \"text-block\"><span>Place islets back in the incubator at 37 \u00b0C and 5% CO<\/span><span style = \"vertical-align:sub;\">2<\/span><span> for 2 hrs  <\/span><\/div><div class = \"text-block\">Remove 3 x 5 \u00b5L aliquots from the microcentrifuge tube<\/div><div class = \"text-block\">Dilute all 6 aliquots to a final volume of 100 \u00b5L with IS and Hyd-BSA as described in \"Calibration Curves with BSS\" section <\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Islet Lysis<\/span><\/div><div class = \"text-block\">Remove remaining BSS (except the last 10 \u00b5L) from the tube that contained islets.<\/div><div class = \"text-block\"><span>Lysis is performed using an acid ethanol mixture as described previously.<\/span><span style = \"vertical-align:super;\">2<\/span><span style = \"vertical-align:super;\"> <\/span><\/div><div class = \"text-block\">Transfer lysate to a low adsorption vial.<\/div><div class = \"text-block\">Dry completely with nitrogen gas.<\/div><div class = \"text-block\">Reconstitute dried solute with Hyd-BSA to make lysate stock solution.<\/div><div class = \"text-block\">Determine LC-MS response of stock solution.<\/div><div class = \"text-block\">Dilute stock solution appropriately to ensure response of analytes fit within calibration range (multiple dilutions may be necessary).<\/div><div class = \"text-block\">Maintain final sample volumes for these lysate samples at 100 \u00b5L including addition of described IS volume (35 \u00b5L)<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">LC-MS Experiments<\/span><\/div><div class = \"text-block\"><span>Mobile phases (MP):  H<\/span><span style = \"vertical-align:sub;\">2<\/span><span>O with 0.1% FA (MPA) and ACN with 0.1% FA (MPB)<\/span><\/div><div class = \"text-block\">Injection volume: 5 \u00b5L<\/div><div class = \"text-block\"><span>MP flowrate: 0.2 mL min<\/span><span style = \"vertical-align:super;\">-1<\/span><\/div><div class = \"text-block\">Column temperature: 30 \u00b0C<\/div><div class = \"text-block\">Optimized gradient: 21.3% MPB and held for 1 min. The MP composition underwent a linear change to 45.9% MPB over 4.55 min. The last 8 min of the method switched between 65% MPB and 21.3% MPB every 2 min.<\/div><div class = \"text-block\">Operate mass spectrometer in selected reaction monitoring mode (SRM) <\/div><div class = \"text-block\"><span>Electrospray settings: spray voltage of 3500 V, sheath gas setting of 4.09 L min<\/span><span style = \"vertical-align:super;\">-1<\/span><span>, an auxiliary gas setting of 6.4 L min<\/span><span style = \"vertical-align:super;\">-1<\/span><span>, ion transfer tube temperature of 325 \u00b0C, and a capillary temperature of 350 \u00b0C<\/span><\/div><div class = \"text-block\">Transitions used were:<\/div><table border><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\"><\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\"><\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\"><\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\"><\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Transition<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Collision Energy (eV)<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Somatostatin<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">819 --> 221<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">40.6<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Somatostatin IS<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">822 --> 221<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">41.7<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">C-peptide<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">1007 --> 927<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">22.9<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">C-peptide IS<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">1011 --> 939<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">22.4<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Insulin<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">968 --> 1129<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">20.6<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Insulin IS<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">979 --> 1148<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">18.3<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Glucagon<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">871 --> 1084<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">24.2<\/td><\/tr><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">Glucagon IS<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">873 --> 1004<\/td><td rowspan = \"\" colspan = \"\" style =\"display : table-cell;\">26.4<\/td><\/tr><\/table><div class = \"text-block\">If desired, directly infuse each analyte and IS (no Hyd-BSA in solution) to develop other transitions. <\/div><div class = \"text-block\">SRM dwell time - 50 ms<\/div><div class = \"text-block\">Daily calibration curves for quantitation of islet secretion and lysate samples using the low (0.5 nM) and high (20 nM) calibrants are recommended.<\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">Data Analysis<\/span><\/div><div class = \"text-block\">Plot average ratio of analyte peak area to IS peak area at each analyte concentration from three runs to build calibration curves.<\/div><div class = \"text-block\">Fit data with linear trendlines.<\/div><div class = \"text-block\">Utilize to interpolate concentrations of analyte from islet and lysate samples.<\/div><div class = \"text-block\">The concentrations of each hormone in each of the fractions were then converted to pmol by accounting for dilutions.<\/div><div class = \"text-block\">The amounts of each hormone secreted can be further described by:<\/div><div class = \"text-block\"><span style = \"font-style:italic;\">a) Reporting secretion amounts as a percent of total hormone:<\/span><\/div><div class = \"text-block\">Calculate the moles of peptides secreted from islets and islet lysate by determining concentrations from the analyzed samples and taking into account the total dilution performed.<\/div><div class = \"text-block\"><span>Calculate the percentage of each hormone release, with respect to the total content of that hormone, per minute of incubation time at each glucose condition.<\/span><span style = \"vertical-align:super;\">3<\/span><\/div><div class = \"text-block\"><span style = \"font-style:italic;\">b) Convert the measured values to pg mL<\/span><span style = \"font-style:italic;vertical-align:super;\">-1<\/span><span style = \"font-style:italic;\"> and normalize to IEQ and incubation time.<\/span><\/div><div class = \"text-block\">Use the average measured values in the 5 \u03bcL aliquots and extrapolate to the total amount in the 50 \u03bcL tube.<\/div><div class = \"text-block\">.<\/div><div class = \"text-block\"><span style = \"font-style:italic;font-weight:bold;\">Disclaimer: Reproduction of the separation method is highly dependent on having a well-conditioned column. We have found that a brand new column does not provide the same separation as one that has undergone numerous injections of analytes and IS. It is highly recommended to condition the column with repeated injections (minimum 150) using high concentrations (> 400 nM) of all analytes and IS diluted with Hyd-BSA.<\/span><\/div><div class = \"text-block\"><span style = \"font-weight:bold;\">References<\/span><\/div><div class = \"text-block\">1. F. Verbeke, N. Bracke, N. Debunne, E. Wynendaele, B. De Spiegeleer, LC-MS Compatible Antiadsorption Diluent for Peptide Analysis, Anal. Chem. 92 (2020) 1712\u20131719. <\/div><div class = \"text-block\">2. P. Detimary, J.C. Jonas, J.C. Henquin, Stable and diffuseable pools of nucleotides in pancreatic islet cells, Endocrinology. 137 (1996) 4671\u20134676.<\/div><div class = \"text-block\">3. J.C. Henquin, The challenge of correctly reporting hormones content and secretion in isolated human islets, Mol. Metab. 30 (2019) 230\u2013239. <\/div><\/div>","materials":[],"description":"<div class = \"text-blocks\"><div class = \"text-block\">An LC-MS method using multiple reaction monitoring for quantitation of insulin, C-peptide, glucagon, and somatostatin secretion from human islet populations is described. A 5 min separation was developed using a 2.1 \u00d7 30 mm (i.d. x length) C18 column. The method was used to measure secretions from static incubations of human islets from 2 donors. Insulin and C-peptide matched well with reported values of these hormones.<\/div><\/div>","changed_on":1620853215}